BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

SineuGene Secures Dual U.S. and China IND Clearances for First-in-Class ALS Gene Therapy SNUG01

SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, anno...

August 18, 2025 | News

Leads Biolabs Completes Patient Enrollment in World’s First Registrational Trial of Immunotherapy for Advanced EP-NEC

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced the successful completion of patient enrollment in t...

August 15, 2025 | News

China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus

The first seven months of 2025 saw robust dealmaking in China’s biopharma and healthcare sector, even as global headwinds tempered some activity. Chi...

August 15, 2025 | Report

Remegen’s Telitacicept Hits Phase III Milestone in Primary Sjögren’s Syndrome

Remegen (688331.SH/09995.HK) announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met the primary endp...

August 14, 2025 | News

Fosun Pharma Licenses XH-S004 to Expedition in US$645M Deal

Fosun Pharma announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) t...

August 13, 2025 | News

WuXi Biologics Achieves Fully Automated Continuous Drug Substance Manufacturing at Pilot Scale with WuXiUP™ Platform

Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the ...

August 13, 2025 | News

Mabwell Doses First U.S. Patient in Global Trial of Novel Nectin-4 ADC for Hard-to-Treat Triple-Negative Breast Cancer

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced the first patient dosing in the U.S. for a clinical stud...

August 13, 2025 | News

Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm

Local health authorities reported thousands of cases within weeks; by early August, figures converged around the several-thousand mark, with some reports t...

August 11, 2025 | Analysis

RemeGen Secures FDA Clearance for Phase II Trials of Innovative Bispecific Antibody RC148 in Advanced Solid Tumors

RemeGen Co., announces clearance of IND application by Food and Drug Administration (FDA) for phase II clinical trials for its independently-developed bisp...

August 11, 2025 | News

GenScript Launches ‘Scripting Possibilities’—A Bold Global Brand Identity to Power the Future of Life Sciences

GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, unveiled its new global brand platform: Scripting Possibilities...

August 11, 2025 | News

Minghui Pharmaceutical Secures $131M Pre-IPO Funding to Accelerate Global Pipeline

Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced the closing of a USD 131 million Pre-IPO fin...

August 08, 2025 | News

Biocair Expands APAC Footprint with New Shanghai Office to Meet Soaring Life Science Logistics Demand

Biocair, an established global leader in life science logistics, announces the further expansion of its operations in the APAC region with the opening...

August 07, 2025 | News

Fapon Biopharma Enrolls First Patient in China Phase I Trial of Novel Immunotherapy FP008 for Solid Tumors

Fapon Biopharma, a biotech in developing therapeutic antibodies and fusion proteins, is delighted to announce the completion of the first patient enrollmen...

August 06, 2025 | News

Bracco Imaging’s SonoVue® Gains NMPA Approval for HyCoSy Use in Infertility Diagnosis in China

Bracco Imaging, a global leader in diagnostic imaging,announced that its ultrasound contrast agent SonoVue® has been approved by the China's&...

August 06, 2025 | News

Stay Connected